CDER Program Allows Regulators to Gain Insight into Pharma Industry

US regulators announced this week that they intend to continue a program they say allows companies to invite pharmaceutical regulatory officials into their facilities to go on site tours to learn more about the pharmaceutical industry and the way it produces its products.The plan, known as the Regulatory Project Management Site Tours and Regulatory Interaction Program, or the Site Tours Program, has been in effect in various forms since 1999, when it was created by the Center for Drug Evaluation Research's (CDER) Training and Certification Subcommittee.